{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:23:55Z","timestamp":1779099835032,"version":"3.51.4"},"reference-count":194,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T00:00:00Z","timestamp":1705795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Warsaw Scientific Projects","award":["1MA\/N\/2022"],"award-info":[{"award-number":["1MA\/N\/2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The present review draws attention to the specific role of angiotensin peptides [angiotensin II (Ang II), angiotensin-(1-7) (Ang-(1-7)], vasopressin (AVP), and insulin in the regulation of the coronary blood flow and cardiac contractions. The interactions of angiotensin peptides, AVP, and insulin in the heart and in the brain are also discussed. The intracardiac production and the supply of angiotensin peptides and AVP from the systemic circulation enable their easy access to the coronary vessels and the cardiomyocytes. Coronary vessels and cardiomyocytes are furnished with AT1 receptors, AT2 receptors, Ang (1-7) receptors, vasopressin V1 receptors, and insulin receptor substrates. The presence of some of these molecules in the same cells creates good conditions for their interaction at the signaling level. The broad spectrum of actions allows for the engagement of angiotensin peptides, AVP, and insulin in the regulation of the most vital cardiac processes, including (1) cardiac tissue oxygenation, energy production, and metabolism; (2) the generation of the other cardiovascular compounds, such as nitric oxide, bradykinin (Bk), and endothelin; and (3) the regulation of cardiac work by the autonomic nervous system and the cardiovascular neurons of the brain. Multiple experimental studies and clinical observations show that the interactions of Ang II, Ang(1-7), AVP, and insulin in the heart and in the brain are markedly altered during heart failure, hypertension, obesity, and diabetes mellitus, especially when these diseases coexist. A survey of the literature presented in the review provides evidence for the belief that very individualized treatment, including interactions of angiotensins and vasopressin with insulin, should be applied in patients suffering from both the cardiovascular and metabolic diseases.<\/jats:p>","DOI":"10.3390\/ijms25021310","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T03:50:22Z","timestamp":1705895422000},"page":"1310","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Interplay of Angiotensin Peptides, Vasopressin, and Insulin in the Heart: Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3761-508X","authenticated-orcid":false,"given":"Ewa","family":"Szczepanska-Sadowska","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Bakkar, N.Z., Dwaib, H.S., Fares, S., Eid, A.H., Al-Dhaheri, Y., and El-Yazbi, A.F. (2020). Cardiac Autonomic Neuropathy: A Progressive Consequence of Chronic Low-Grade Inflammation in Type 2 Diabetes and Related Metabolic Disorders. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239005"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1253\/circj.CJ-08-1012","article-title":"Cardiac adiposity and global cardiometabolic risk: New concept and clinical implication","volume":"73","author":"Shimabukuro","year":"2009","journal-title":"Circ. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","article-title":"Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms","volume":"34","author":"Petrie","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Severino, P., D\u2019Amato, A., Pucci, M., Infusino, F., Adamo, F., Birtolo, L.I., Netti, L., Montefusco, G., Chimenti, C., and Lavalle, C. (2020). Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218118"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI115260","article-title":"Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans","volume":"87","author":"Anderson","year":"1991","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"E435","DOI":"10.1152\/ajpendo.00391.2014","article-title":"Modulation of glucose metabolism by the renin-angiotensin-aldosterone system","volume":"308","author":"Favre","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11906-018-0823-9","article-title":"Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders","volume":"20","author":"Czarzasta","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Szczepanska-Sadowska, E. (2022). The Heart as a Target of Vasopressin and Other Cardiovascular Peptides in Health and Cardiovascular Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232214414"},{"key":"ref_9","unstructured":"Szczepanska-Sadowska, E., \u017bera, T., Kowara, M., and Cudnoch-Jedrzejewska, A. (2023). Angiotensin from the Kidney to Coronavirus. Molecular Mediators in Health and Disease: How Cells Communicate, Academic Press-Elsevier."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Dhalla, N.S., Shah, A.K., and Tappia, P.S. (2020). Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072413"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1080\/13813455.2020.1729816","article-title":"The role of vasopressin V1A and oxytocin OTR receptors in protective effects of arginine vasopressin against H2O2-induced oxidative stress in H9C2 cells","volume":"128","author":"Ghorbanzadeh","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez, P., Lozano, P., Ros, G., and Solano, F. (2023). Hyperglycemia and Oxidative Stress: An Integral, Updated and Critical Overview of Their Metabolic Interconnections. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119352"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Masenga, S.K., Kabwe, L.S., Chakulya, M., and Kirabo, A. (2023). Mechanisms of Oxidative Stress in Metabolic Syndrome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24097898"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s13300-019-00693-0","article-title":"Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review","volume":"10","author":"Williams","year":"2019","journal-title":"Diabetes Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"R276","DOI":"10.1152\/ajpregu.00280.2020","article-title":"Mineralocorticoid receptors in the pathogenesis of insulin resistance and related disorders: From basic studies to clinical disease","volume":"320","author":"Jia","year":"2021","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart Failure in Type 2 Diabetes Mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"873301","DOI":"10.3389\/fendo.2022.873301","article-title":"Significance of Brain Glucose Hypometabolism, Altered Insulin Signal Transduction, and Insulin Resistance in Several Neurological Diseases","volume":"13","author":"Pozo","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4093\/dmj.2021.0280","article-title":"Insulin Resistance: From Mechanisms to Therapeutic Strategies","volume":"46","author":"Lee","year":"2022","journal-title":"Diabetes Metab. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1034170","DOI":"10.3389\/fphys.2023.1034170","article-title":"Role of the renin-angiotensin system in the pathophysiology of coronary heart disease and heart failure: Diagnostic biomarkers and therapy with drugs and natural products","volume":"14","author":"Mehta","year":"2023","journal-title":"Front. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2174\/1389200218666170119145900","article-title":"Vasopressin and related peptides; potential value in diagnosis, prognosis and treatment of clinical disorders","volume":"18","author":"Zera","year":"2017","journal-title":"Curr. Drug Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro","volume":"75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/cvr\/cvq004","article-title":"Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts","volume":"86","author":"Gembardt","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_23","first-page":"160","article-title":"Involvement of the mitochondrial permeability transition pore in angiotensin II-mediated apoptosis","volume":"10","author":"Ricci","year":"2005","journal-title":"Exp. Clin. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.RES.88.5.529","article-title":"Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction","volume":"88","author":"Ide","year":"2001","journal-title":"Circ. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","article-title":"Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure","volume":"108","author":"Dai","year":"2011","journal-title":"Circ. Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bhullar, S.K., and Dhalla, N.S. (2022). Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy. Cells, 11.","DOI":"10.3390\/cells11213336"},{"key":"ref_27","first-page":"111","article-title":"Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium","volume":"84","author":"Giacomelli","year":"1976","journal-title":"Am. J. Pathol."},{"key":"ref_28","first-page":"60","article-title":"Adrenoreceptor blockade in angiotensin-induced hypertension: Effect on rat coronary arteries and myocardium","volume":"108","author":"Bhan","year":"1982","journal-title":"Am. J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"R1512","DOI":"10.1152\/ajpregu.00014.2008","article-title":"Contrasting effect of exercise and angiotensin II hypertension on in vivo and in vitro cardiac angiogenesis in rats","volume":"295","author":"Belabbas","year":"2008","journal-title":"Am. J. Physiol. Regu. Integr. Comp. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1291\/hypres.23.677","article-title":"Effects of valsartan on angiotensin II-induced migration of human coronary artery smooth muscle cells","volume":"23","author":"Kohno","year":"2000","journal-title":"Hypertens. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"H1232","DOI":"10.1152\/ajpheart.00040.2004","article-title":"ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells","volume":"287","author":"Hafizi","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/FJC.0000000000000118","article-title":"Gene and microRNA transcriptional signatures of angiotensin II in endothelial cells","volume":"65","author":"Mehta","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.RES.60.3.422","article-title":"Endothelial renin-angiotensin pathway: Evidence for intracellular synthesis and secretion of angiotensins","volume":"60","author":"Kifor","year":"1987","journal-title":"Circ. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/ajh\/4.4.321","article-title":"Autoradiographic localization and quantification of rat heart angiotensin converting enzyme","volume":"4","author":"Pinto","year":"1991","journal-title":"Am. J. Hypertens."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/01.RES.68.1.141","article-title":"Localization of angiotensin converting enzyme in rat heart","volume":"68","author":"Yamada","year":"1991","journal-title":"Circ. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"H1087","DOI":"10.1152\/ajpheart.2000.279.3.H1087","article-title":"Coronary microvascular endothelial cells cosecrete angiotensin II and endothelin-1 via a regulated pathway","volume":"279","author":"Kusaka","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI117710","article-title":"The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells","volume":"95","author":"Stoll","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"H746","DOI":"10.1152\/ajpheart.00431.2010","article-title":"Both AT1 and AT2 receptors mediate proliferation and migration of porcine vascular smooth muscle cells","volume":"301","author":"Louis","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/01.HYP.30.6.1621","article-title":"Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: Effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis","volume":"30","author":"Takemoto","year":"1997","journal-title":"Hypertension"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1172\/JCI119156","article-title":"Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats","volume":"99","author":"Takemoto","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0735-1097(97)00112-5","article-title":"Bradykinin-induced vasodilation of human coronary arteries in vivo: Role of nitric oxide and angiotensin-converting enzyme","volume":"30","author":"Kuga","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0735-1097(98)00611-1","article-title":"Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: A potential role of bradykinin","volume":"33","author":"Prasad","year":"1999","journal-title":"J. Am. Coll\/Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1291\/hypres.26.749","article-title":"Effects of angiotensin II on nitric oxide generation in proliferating and quiescent rat coronary microvascular endothelial cells","volume":"26","author":"Bayraktutan","year":"2003","journal-title":"Hypertens. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1161\/HYPERTENSIONAHA.106.080242","article-title":"Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway","volume":"49","author":"Munk","year":"2007","journal-title":"Hypertension"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1111\/jcmm.14926","article-title":"Hyperbaric oxygen activates visfatin expression and angiogenesis via angiotensin II and JNK pathway in hypoxic human coronary artery endothelial cells","volume":"24","author":"Chiu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"ref_46","first-page":"325","article-title":"Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology","volume":"46","author":"Rubanyi","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"H226","DOI":"10.1152\/ajpheart.00480.2008","article-title":"Regulation of coronary vascular tone via redox modulation in the alpha1-adrenergic-angiotensin-endothelin axis of the myocardium","volume":"296","author":"Yamaguchi","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"H2069","DOI":"10.1152\/ajpheart.01163.2007","article-title":"Integrative control of coronary resistance vessel tone by endothelin and angiotensin II is altered in swine with a recent myocardial infarction","volume":"294","author":"Sorop","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10741-017-9644-1","article-title":"Epicardial adipose tissue as a metabolic transducer: Role in heart failure and coronary artery disease","volume":"22","author":"Patel","year":"2017","journal-title":"Heart Fail. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"H202","DOI":"10.1152\/ajpheart.00120.2010","article-title":"Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress","volume":"299","author":"Eiras","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_51","first-page":"911","article-title":"Increased angiotensinogen production in epicardial adipose tissue during cardiac surgery: Possible role in a postoperative insulin resistance","volume":"57","author":"Kremen","year":"2008","journal-title":"Physiol Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e13463","DOI":"10.1111\/eci.13463","article-title":"Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer","volume":"51","author":"Alvarez","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1476-5381.1994.tb14787.x","article-title":"Release of nitric oxide by angiotensin-(1\u20137) from porcine coronary endothelium: Implications for a novel angiotensin receptor","volume":"111","author":"Bara","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/01.HYP.35.4.998","article-title":"Angiotensin-(1\u20137) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man","volume":"35","author":"Ueda","year":"2000","journal-title":"Hypertension"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1590\/S0100-879X2005000400003","article-title":"Cardiovascular actions of angiotensin-(1\u20137)","volume":"38","author":"Ferreira","year":"2005","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phrs.2015.06.018","article-title":"Novel players in cardioprotection: Insulin like growth factor-1, angiotensin-(1\u20137) and angiotensin-(1\u20139)","volume":"101","author":"Westermeier","year":"2015","journal-title":"Pharmacol. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.HYP.38.1.95","article-title":"Bradykinin potentiation by angiotensin-(1\u20137) and ACE inhibitors correlates with ACE C- and N-domain blockade","volume":"38","author":"Tom","year":"2001","journal-title":"Hypertension"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1590\/S0100-879X2000000600012","article-title":"Angiotensin-(1\u20137) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart","volume":"33","author":"Almeida","year":"2000","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1742-7843.2007.00057.x","article-title":"On the mechanism of coronary vasodilation induced by angiotensin-(1\u20137) in the isolated guinea pig heart","volume":"100","author":"Kozlovski","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e13505","DOI":"10.14814\/phy2.13505","article-title":"Cardiovascular effects of small peptides of the renin angiotensin system","volume":"5","author":"Moraes","year":"2017","journal-title":"Physiol. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0006-8993(01)03093-1","article-title":"Subfornical organ neurons projecting to paraventricular nucleus: Whole-cell properties","volume":"921","author":"Anderson","year":"2001","journal-title":"Brain Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-55532-9_1","article-title":"The sensory circumventricular organs of the mammalian brain","volume":"Volume 172","author":"McKinley","year":"2003","journal-title":"Advances in Anatomy, Embryology and Cell Biology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1111\/j.1440-1681.1996.tb02821.x","article-title":"Physiological actions of angiotensin II mediated by AT1 and AT2 receptors in the brain","volume":"23","author":"McKinley","year":"1996","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1523\/JNEUROSCI.6262-11.2012","article-title":"Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension","volume":"32","author":"Capone","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005344-199602000-00005","article-title":"Preservation of left ventricular mechanical function and energy metabolism in rats after myocardial infarction by the angiotensin-converting enzyme inhibitor quinapril","volume":"27","author":"Horn","year":"1996","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0003-4975(98)00450-0","article-title":"Beneficial effects of angiotensin-converting enzyme inhibitors during acute revascularization","volume":"66","author":"Lazar","year":"1998","journal-title":"Ann. Thorac. Surg."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.bjp.0703555","article-title":"L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: Effect of ACE inhibition","volume":"131","author":"Danser","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.bjp.0704862","article-title":"Bradykinin potentiation by ACE inhibitors: A matter of metabolism","volume":"137","author":"Tom","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1515\/hsz-2012-0348","article-title":"ACE inhibition enhances bradykinin relaxations through nitric oxide and B1 receptor activation in bovine coronary arteries","volume":"394","author":"Gauthier","year":"2013","journal-title":"Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0735-1097(01)01494-2","article-title":"Attenuation of angiotensin II-mediated coronary vasoconstriction and vasodilatory action of angiotensin-converting enzyme inhibitor in pacing-induced heart failure in dogs","volume":"38","author":"Oikawa","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0735-1097(02)01929-0","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: Role of bradykinin","volume":"40","author":"Kitakaze","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1291\/hypres.27.685","article-title":"Effects of angiotensin II type 1 receptor antagonist on smooth muscle cell phenotype in intramyocardial arteries from spontaneously hypertensive rats","volume":"27","author":"Kubo","year":"2004","journal-title":"Hypertens. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/j.1582-4934.2012.01623.x","article-title":"Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction","volume":"16","author":"Babick","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.febslet.2005.01.068","article-title":"The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy","volume":"579","author":"Tanaka","year":"2005","journal-title":"FEBS Lett."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1136\/jim-2020-001328","article-title":"Effect of ischemic postconditioning on cell apoptosis and expression of relevant genes in non-culprit coronary arteries","volume":"68","author":"Wang","year":"2020","journal-title":"J. Investig. Med."},{"key":"ref_76","first-page":"H1918","article-title":"Role of central AT1 and V1 receptors in cardiovascular adaptation to hemorrhage in SD and renin TGR rats","volume":"276","author":"Paczwa","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1152\/japplphysiol.00573.2004","article-title":"ANG II in the paraventricular nucleus potentiates the cardiac sympathetic afferent reflex in rats with heart failure","volume":"97","author":"Zhu","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0735-1097(01)01539-X","article-title":"Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: Extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction","volume":"38","author":"Hayashi","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0735-1097(01)01511-X","article-title":"Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis","volume":"38","author":"Prasad","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1253\/circj.67.535","article-title":"Angiotensin-converting enzyme inhibitor promotes coronary collateral circulation in patients with coronary artery disease","volume":"67","author":"Miura","year":"2003","journal-title":"Circ. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"H17","DOI":"10.1152\/ajpheart.00452.2002","article-title":"In vivo measurement of coronary circulation angiotensin-converting enzyme activity in humans","volume":"284","author":"Staniloae","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"H1425","DOI":"10.1152\/ajpheart.00783.2003","article-title":"ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles","volume":"286","author":"Tiefenbacher","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1253\/circj.CJ-10-0395","article-title":"Addition of losartan to angiotensin-converting enzyme inhibitors improves insulin resistance in patients with chronic heart failure treated without \u03b2-blockers","volume":"74","author":"Ogino","year":"2010","journal-title":"Circ. J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1742-7843.2004.t01-1-pto950504.x","article-title":"Angiotensin II receptor mRNA expression and vasoconstriction in human coronary arteries: Effects of heart failure and age","volume":"95","author":"Wackenfors","year":"2004","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3317\/jraas.2008.005","article-title":"Angiotensin type 2 receptor is expressed in human atherosclerotic lesions","volume":"9","author":"Johansson","year":"2008","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"H1113","DOI":"10.1152\/ajpheart.00828.2006","article-title":"The nonpeptide angiotensin-(1\u20137) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction","volume":"292","author":"Ferreira","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cardfail.2010.04.002","article-title":"Effects of ACE2 inhibition in the post-myocardial infarction heart","volume":"16","author":"Kim","year":"2010","journal-title":"J. Card. Fail."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"H827","DOI":"10.1152\/ajpheart.00814.2014","article-title":"Activation of angiotensin II type 2 receptor suppresses TNF-\u03b1-induced ICAM-1 via NF-\u03baB: Possible role of ACE","volume":"309","author":"Zhu","year":"2015","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00380-019-01478-y","article-title":"Relationship between circulating levels of angiotensin-converting enzyme 2-angiotensin-(1\u20137)-MAS axis and coronary heart disease","volume":"35","author":"Zhou","year":"2020","journal-title":"Heart Vessels"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cmet.2021.01.016","article-title":"Diabetes, obesity, metabolism, and SARS-CoV-2 infection: The end of the beginning","volume":"33","author":"Drucker","year":"2021","journal-title":"Cell Metab."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s44161-023-00336-5","article-title":"SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels","volume":"2","author":"Eberhardt","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"772865","DOI":"10.3389\/fendo.2021.772865","article-title":"COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy","volume":"12","author":"Xie","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3346\/jkms.1997.12.5.391","article-title":"The angiotensin converting enzyme genetic polymorphism in acute coronary syndrome--ACE polymorphism as a risk factor of acute coronary syndrome","volume":"12","author":"Park","year":"1997","journal-title":"J. Korean Med. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0735-1097(00)00902-5","article-title":"The insertion\/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity","volume":"36","author":"Prasad","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.4238\/2013.December.19.8","article-title":"Effects of ACE polymorphisms and other risk factors on the severity of coronary artery disease","volume":"12","author":"Guney","year":"2013","journal-title":"Genet. Mol. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.91.9.3662","article-title":"Insertion\/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus","volume":"91","author":"Ruiz","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1470320310376425","article-title":"Angiotensinogen gene polymorphism in acute myocardial infarction patients","volume":"12","author":"Mehri","year":"2011","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0735-1097(96)00535-9","article-title":"The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction","volume":"29","author":"Amant","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"H787","DOI":"10.1152\/ajpheart.00974.2005","article-title":"Hyperinsulinemia: Effect on cardiac mass\/function, angiotensin II receptor expression, and insulin signaling pathways","volume":"291","author":"Samuelsson","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1194\/jlr.M085886","article-title":"Angiotensin II induces cholesterol accumulation and impairs insulin secretion by regulating ABCA1 in beta cells","volume":"59","author":"Lyu","year":"2018","journal-title":"J. Lipid. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11892-007-0007-5","article-title":"The renin-angiotensin system and insulin resistance","volume":"7","author":"Liu","year":"2007","journal-title":"Curr. Diab. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1097\/00004872-200410000-00021","article-title":"Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity","volume":"22","author":"Furuhashi","year":"2004","journal-title":"J. Hypertens."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2337\/db12-0792","article-title":"Angiotensin 1\u20137 as means to prevent the metabolic syndrome: Lessons from the fructose-fed rat model","volume":"62","author":"Marcus","year":"2013","journal-title":"Diabetes"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.115.06935","article-title":"Chronic Angiotensin-(1\u20137) Improves Insulin Sensitivity in High-Fat Fed Mice Independent of Blood Pressure","volume":"67","author":"Williams","year":"2016","journal-title":"Hypertension"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.31083\/j.rcm2203083","article-title":"Role of the ACE2\/Ang-(1\u20137)\/Mas axis in glucose metabolism","volume":"22","author":"Zhao","year":"2021","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/HYPERTENSIONAHA.109.146605","article-title":"Glutamatergic receptor activation in the rostral ventrolateral medulla mediates the sympathoexcitatory response to hyperinsulinemia","volume":"55","author":"Bardgett","year":"2010","journal-title":"Hypertension"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/jnc.13842","article-title":"Age-dependent alterations to paraventricular nucleus insulin-like growth factor 1 receptor as a possible link between sympathoexcitation and inflammation","volume":"139","author":"Ogundele","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1253\/circj.CJ-12-1163","article-title":"Increased tissue angiotensin-converting enzyme activity impairs bradykinin-induced dilation of coronary arterioles in obesity","volume":"77","author":"Feher","year":"2013","journal-title":"Circ. J."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/01.HYP.0000125142.41703.64","article-title":"Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice","volume":"43","author":"Shiuchi","year":"2004","journal-title":"Hypertension"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/HYPERTENSIONAHA.111.183178","article-title":"Roles of interleukin 17 in angiotensin II type 1 receptor-mediated insulin resistance","volume":"59","author":"Ohshima","year":"2012","journal-title":"Hypertension"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00395-011-0201-0","article-title":"Coronary arterioles in type 2 diabetic (db\/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness","volume":"106","author":"Katz","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.vph.2015.06.013","article-title":"The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice","volume":"76","author":"Husarek","year":"2016","journal-title":"Vascul. Pharmacol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"H833","DOI":"10.1152\/ajpheart.01096.2008","article-title":"Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension","volume":"296","author":"Zhou","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mvr.2013.02.007","article-title":"Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats","volume":"87","author":"Estato","year":"2013","journal-title":"Microvasc. Res."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Oliveira-Junior, S.A., Martinez, P.F., Guizoni, D.M., Campos, D.H., Fernandes, T., Oliveira, E.M., Okoshi, M.P., Okoshi, K., Padovani, C.R., and Cicogna, A.C. (2014). AT1 receptor blockade attenuates insulin resistance and myocardial remodeling in rats with diet-induced obesity. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0086447"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.steroids.2014.08.016","article-title":"Effects of aldosterone on insulin sensitivity and secretion","volume":"91","author":"Luther","year":"2014","journal-title":"Steroids"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.tem.2018.08.001","article-title":"Metabolic Stress, Autophagy, and Cardiovascular Aging: From Pathophysiology to Therapeutics","volume":"29","author":"Ren","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Igbekele, A.E., Jia, G., Hill, M.A., Sowers, J.R., and Jia, G. (2022). Mineralocorticoid Receptor Activation in Vascular Insulin Resistance and Dysfunction. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23168954"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2337\/dc09-1381","article-title":"Effect of Renin-Angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose tolerance","volume":"33","author":"Pscherer","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Yang, F.S., Yun, C.H., Wu, T.H., Hsieh, Y.C., Bezerra, H.G., Liu, C.C., Wu, Y.J., Kuo, J.Y., Hung, C.L., and Hou, C.J. (2013). High pericardial and peri-aortic adipose tissue burden in pre-diabetic and diabetic subjects. BMC Cardiovasc. Disord., 13.","DOI":"10.1186\/1471-2261-13-98"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1042\/bj3430673","article-title":"Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta","volume":"343","author":"Nelson","year":"1999","journal-title":"Biochem. J."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/21623945.2015.1131881","article-title":"ACE2\/Ang 1\u20137 axis: A critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity","volume":"5","author":"Patel","year":"2016","journal-title":"Adipocyte"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1152\/ajpendo.00192.2017","article-title":"Angiotensin 1\u20137 stimulates brown adipose tissue and reduces diet-induced obesity","volume":"314","author":"Morimoto","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0079-6123(08)64379-4","article-title":"Vasopressin and oxytocin: Distribution and putative functions in the brain","volume":"60","author":"Buijs","year":"1983","journal-title":"Prog. Brain Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.RES.84.3.365","article-title":"Evidence for a vasopressin system in the rat heart","volume":"84","author":"Hupf","year":"1999","journal-title":"Circ. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.npep.2015.03.003","article-title":"The secretion patterns and roles of cardiac and circulating arginine vasopressin during the development of heart failure","volume":"51","author":"Chen","year":"2015","journal-title":"Neuropeptides"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/eurheartj\/ehv320","article-title":"CardioPulse: \u2019Ten Commandments\u2019 of 2015 European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (NSTE-ACS)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yfrne.2017.10.004","article-title":"Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery","volume":"51","author":"Song","year":"2018","journal-title":"Front. Neuroendocrinol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/endo.131.1.1535312","article-title":"Distribution of V1a and V2 vasopressin receptor messenger ribonucleic acids in rat liver, kidney, pituitary and brain","volume":"131","author":"Ostrowski","year":"1992","journal-title":"Endocrinology"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"E566","DOI":"10.1152\/ajpendo.00148.2003","article-title":"Pancreatic vasopressin V1b receptors: Characterization in In-R1-G9 cells and localization in human pancreas","volume":"285","author":"Folny","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000108655","article-title":"Vasopressin receptor mRNA expression in the human gastrointestinal tract","volume":"40","author":"Monstein","year":"2008","journal-title":"Eur. Surg. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygcen.2017.10.011","article-title":"Neuroanatomical distribution and function of the vasopressin V1B receptor in the rat brain deciphered using specific fluorescent ligands","volume":"258","author":"Corbani","year":"2018","journal-title":"Gen. Comp. Endocrinol."},{"key":"ref_135","first-page":"349","article-title":"Vasopressin V1a, V1b and V2 receptors mRNA in the kidney and heart of the renin transgenic TGR(mRen2)27 and Sprague Dawley rats","volume":"53","author":"Luszczyk","year":"2002","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0167-0115(93)90182-8","article-title":"Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors","volume":"45","author":"Morel","year":"1993","journal-title":"Regul. Pept."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"H2262","DOI":"10.1152\/ajpheart.01320.2006","article-title":"Functional arginine vasopressin system in early heart maturation","volume":"293","author":"Gutkowska","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1440-1681.1990.tb01278.x","article-title":"Intracerebroventricular infusions of insulin increase vasopressin release in rats","volume":"17","author":"Nishimura","year":"1990","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0006-8993(01)02404-0","article-title":"Arginine-vasopressin in nucleus of the tractus solitarius induces hyperglycemia and brain glucose retention","volume":"902","author":"Yarkov","year":"2001","journal-title":"Brain Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-4419-9280-2_12","article-title":"Enhancing effect of vasopressin on the hyperglycemic response to carotid body chemoreceptor stimulation. Role of metabolic variables","volume":"536","author":"Montero","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1152\/japplphysiol.01414.2005","article-title":"Arginine-vasopressin mediates central and peripheral glucose regulation in response to carotid body receptor stimulation with Na-cyanide","volume":"100","author":"Montero","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1210\/endo.138.10.5270","article-title":"Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat","volume":"138","author":"Larsen","year":"1997","journal-title":"Endocrinology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1471-4159.1999.0720010.x","article-title":"Coexpression of glucagon-like peptide-1 (GLP-1) receptor, vasopressin, and oxytocin mRNAs in neurons of the rat hypothalamic supraoptic and paraventricular nuclei: Effect of GLP-1(7\u201336)amide on vasopressin and oxytocin release","volume":"72","author":"Zueco","year":"1999","journal-title":"J. Neurochem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0300-9629(91)90304-U","article-title":"Vasopressin increases blood glucose in pygmy goats (Capra hircus) by an alpha-adrenergic mechanism","volume":"100","author":"Rossi","year":"1991","journal-title":"Comp. Biochem. Physiol. A Comp. Physiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.peptides.2009.01.024","article-title":"Nitric oxide mediates feedback inhibition in angiotensin II-induced upregulation of vasopressin mRNA","volume":"30","author":"Zhang","year":"2009","journal-title":"Peptides"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.vph.2004.01.001","article-title":"Comparison of the in vivo coronary action of endothelin-1 and vasopressin role of nitric oxide and prostanoids","volume":"40","author":"Monge","year":"2003","journal-title":"Vascul. Pharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neulet.2005.02.040","article-title":"Inhibitory effect of gaseous neuromodulators in vasopressin and oxytocin release induced by endotoxin in rats","volume":"381","author":"Elias","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.10.021","article-title":"Participation of iNOS-derived NO in hypothalamic activation and vasopressin release during polymicrobial sepsis","volume":"183","author":"Pancoto","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e12686","DOI":"10.1111\/jne.12686","article-title":"Nitric oxide acutely modulates hypothalamic and neurohypophyseal carbon monoxide and hydrogen sulphide production to control vasopressin, oxytocin and atrial natriuretic peptide release in rats","volume":"31","author":"Coletti","year":"2019","journal-title":"J. Neuroendocrinol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.CIR.79.6.1324","article-title":"Vasopressin and the mature coronary collateral circulation","volume":"79","author":"Peters","year":"1989","journal-title":"Circulation"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.82.1.1","article-title":"Understanding the coronary circulation through studies at the microvascular level","volume":"82","author":"Marcus","year":"1990","journal-title":"Circulation"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1161\/01.CIR.83.6.2111","article-title":"Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels","volume":"83","author":"Maturi","year":"1991","journal-title":"Circulation"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/01.RES.66.3.710","article-title":"Attenuation of vasopressin-mediated coronary constriction and myocardial depression in the hypoxic heart","volume":"66","author":"Boyle","year":"1990","journal-title":"Circ. Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1365-2044.2004.03877.x","article-title":"Vasopressin and terlipressin: Pharmacology andw its clinical relevance","volume":"59","author":"Kam","year":"2004","journal-title":"Anaesthesia"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.2169\/internalmedicine.55.7513","article-title":"Coronary Spastic Angina Induced after Oral Desmopressin (DDAVP) Administration","volume":"55","author":"Adachi","year":"2016","journal-title":"Intern. Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/01.HYP.30.5.1112","article-title":"Arginine vasopressin increases nitric oxide synthesis in cytokine-stimulated rat cardiac myocytes","volume":"30","author":"Yamamoto","year":"1997","journal-title":"Hypertension"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00004872-199917050-00011","article-title":"Mechanisms underlying arginine vasopressin-induced relaxation in monkey isolated coronary arteries","volume":"17","author":"Okamura","year":"1999","journal-title":"J. Hypertens."},{"key":"ref_158","first-page":"417","article-title":"Arginine vasopressin-induced nitric oxide content changes in cultured cardiac fibroblasts and its relation to nuclear factor-kappaB","volume":"55","author":"Fan","year":"2003","journal-title":"Sheng Li Xue Bao"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCULATIONAHA.111.021352","article-title":"Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through G\u03b1q-mediated cell signaling","volume":"124","author":"Li","year":"2011","journal-title":"Circulation"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.fjc.0000175437.87283.f2","article-title":"Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts","volume":"46","author":"Wagner","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.RES.69.3.657","article-title":"Vasoconstriction of canine coronary collateral vessels with vasopressin limits blood flow to collateral-dependent myocardium during exercise","volume":"69","author":"Foreman","year":"1991","journal-title":"Circ. Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2015.04.006","article-title":"Vasopressin attenuates ischemia-reperfusion injury via reduction of oxidative stress and inhibition of mitochondrial permeability transition pore opening in rat hearts","volume":"760","author":"Nazari","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-200203000-00011","article-title":"Beneficial effects of short-term vasopressin infusion during severe septic shock","volume":"96","author":"Patel","year":"2002","journal-title":"Anesthesiology"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","article-title":"Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study","volume":"107","author":"Mayr","year":"2003","journal-title":"Circulation"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/BF00257428","article-title":"Plasma vasopressin during insulin withdrawal in insulin-dependent diabetes","volume":"20","author":"Milles","year":"1981","journal-title":"Diabetologia"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/jcem-53-5-935","article-title":"Arginine vasopressin response to insulin-induced hypoglycemia in man","volume":"53","author":"Baylis","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1159\/000126185","article-title":"Hypoglycemia-induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood-brain barrier","volume":"55","author":"Chiodera","year":"1992","journal-title":"Neuroendocrinology"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0304-3940(95)11536-6","article-title":"Suppressive effect of vasopressin on the hyperglycemic response to intracranial injection of 2-deoxy-D-glucose","volume":"190","author":"Nagai","year":"1995","journal-title":"Neurosci. Lett."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000441-198811000-00003","article-title":"Oxytocin and vasopressin are present in human and rat pancreas","volume":"296","author":"Amico","year":"1988","journal-title":"Am. J. Med. Sci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0034-5288(97)90129-6","article-title":"Effects of oxytocin, arginine-vasopressin and lysine-vasopressin on insulin and glucagon secretion in sheep","volume":"62","author":"Mineo","year":"1997","journal-title":"Res. Vet. Sci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biochi.2019.01.008","article-title":"Vasopressin receptors in islets enhance glucose tolerance, pancreatic beta-cell secretory function, proliferation and survival","volume":"158","author":"Mohan","year":"2019","journal-title":"Biochimie"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1053\/meta.2002.34052","article-title":"Glucose dependency of arginine vasopressin-induced insulin and glucagon release from the perfused rat pancreas","volume":"51","author":"Hsu","year":"2002","journal-title":"Metabolism"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e72919","DOI":"10.7554\/eLife.72919","article-title":"Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes","volume":"10","author":"Kim","year":"2021","journal-title":"eLife"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000125141","article-title":"Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia","volume":"49","author":"Engler","year":"1989","journal-title":"Neuroendocrinology"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2265.1990.tb03754.x","article-title":"Plasma corticotrophin-releasing factor and vasopressin responses to hypoglycaemia in normal man","volume":"32","author":"Ellis","year":"1990","journal-title":"Clin. Endocrinol."},{"key":"ref_176","first-page":"73","article-title":"The response of regulatory peptides to moderate hypoglycaemia of short duration in type 1 (insulin-dependent) diabetes mellitus and in normal man","volume":"20","author":"Tallroth","year":"1992","journal-title":"Diabetes Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1210\/jcem-65-6-1187","article-title":"Hormonal responses to insulin-induced hypoglycemia in man","volume":"65","author":"Watabe","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1210\/endo.130.5.1315256","article-title":"Stimulation of adrenocorticotropin secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not corticotropin-releasing factor","volume":"130","author":"Muret","year":"1992","journal-title":"Endocrinology"},{"key":"ref_179","first-page":"R653","article-title":"The effect of intracarotid vasopressin infusion on ACTH release in neurohypophysectomized, conscious dogs","volume":"267","author":"Raff","year":"1994","journal-title":"Am. J. Physiol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1677\/JOE-09-0096","article-title":"The stimuli-specific role of vasopressin in the hypothalamus-pituitary-adrenal axis response to stress","volume":"202","author":"Zelena","year":"2009","journal-title":"J. Endocrinol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1007165127420","article-title":"Diabetes increases the expression of hypothalamic neuropeptides in a spontaneous model of type I diabetes, the nonobese diabetic (NOD) mouse","volume":"21","author":"Saravia","year":"2001","journal-title":"Cell Mol. Neurobiol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0014-2999(02)02826-1","article-title":"Vascular reactivity to vasopressin during diabetes: Gender and regional differences","volume":"459","author":"Sanz","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2009.04.008","article-title":"Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance","volume":"613","author":"Nakamura","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/joim.12649","article-title":"Vasopressin and metabolic disorders: Translation from experimental models to clinical use","volume":"282","author":"Nakamura","year":"2017","journal-title":"J. Intern. Med."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"E127","DOI":"10.1152\/ajpendo.00269.2016","article-title":"Acute and chronic hyperglycemic effects of vasopressin in normal rats: Involvement of V1A receptors","volume":"312","author":"Taveau","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s11064-007-9519-2","article-title":"Enhanced expressions of arginine vasopressin (Avp) in the hypothalamic paraventricular and supraoptic nuclei of type 2 diabetic rats","volume":"33","author":"Yi","year":"2008","journal-title":"Neurochem. Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/jcem-68-3-688","article-title":"Arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in type 1 (insulin-dependent) diabetes","volume":"68","author":"Fisher","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"E1065","DOI":"10.1210\/jc.2010-2981","article-title":"Plasma copeptin, a unifying factor behind the metabolic syndrome","volume":"96","author":"Struck","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/dme.12411","article-title":"Copeptin, a surrogate marker for arginine vasopressin secretion, is associated with higher glucose and insulin concentrations but not higher blood pressure in obese men","volume":"31","author":"Asferg","year":"2014","journal-title":"Diabet. Med."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s13679-019-00355-z","article-title":"Oxytocin and Vasopressin Systems in Obesity and Metabolic Health: Mechanisms and Perspectives","volume":"8","author":"Ding","year":"2019","journal-title":"Curr. Obes. Rep."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-2007-1004891","article-title":"Arginine vasopressin response to insulin-induced hypoglycemia in insulin-dependent diabetics with asymptomatic hypoglycemia","volume":"22","author":"Wolf","year":"1990","journal-title":"Horm. Metab. Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/cs0880671","article-title":"Down-regulation of vasopressin V1a receptor mRNA in diabetes mellitus in the rat","volume":"88","author":"Phillips","year":"1995","journal-title":"Clin. Sci."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3945\/ajcn.2008.26382","article-title":"Relation between human vasopressin 1a gene variance, fat intake, and diabetes","volume":"89","author":"Leosdottir","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-15-0781","article-title":"Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus","volume":"174","author":"Hedblad","year":"2016","journal-title":"Eur. J. Endocrinol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/1310\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:46:44Z","timestamp":1760104004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/1310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,21]]},"references-count":194,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25021310"],"URL":"https:\/\/doi.org\/10.3390\/ijms25021310","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,21]]}}}